Sexual Health & Medical Wellness Artificial Intelligence Uncovers Potential Underreported Side Effects of GLP-1 Weight Loss Drugs Through Large-Scale Social Media Analysis October 23, 2026 Susilo Ahmad The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has transformed the landscape of obesity and diabetes treatment. While clinical trials and regulatory bodies have…
Sexual Health & Medical Wellness AI-Powered Analysis of Reddit Conversations Reveals Unreported Patient Experiences with GLP-1 Weight Loss Drugs October 13, 2026 Susilo Ahmad The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound), has fundamentally reshaped the landscape of metabolic…
Sexual Health & Medical Wellness AI-Powered Social Listening Reveals New Patient-Reported Side Effects of Popular GLP-1 Weight Loss Drugs October 5, 2026 Susilo Ahmad Artificial intelligence is giving researchers a new way to listen to what patients are saying about popular GLP-1 drugs, as a recent study from the University of Pennsylvania identifies potential…
Psychology & Intimacy Beyond the Plate and the Pint: How GLP-1 Weight-Loss Medications Are Rewriting the Neuroscience of Addiction and Cravings October 2, 2026 Rebecca Shoemaker For millions of people worldwide, the mere mental image of a savory, freshly grilled burger or the condensation beading on a cold pint of beer can trigger an immediate, vivid…
Sexual Health & Medical Wellness Artificial Intelligence Reveals New Patient-Reported Side Effects of Popular GLP-1 Weight Loss Drugs September 28, 2026 Susilo Ahmad The rapid ascent of GLP-1 receptor agonists—a class of medications including semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) and tirzepatide (marketed as Mounjaro and Zepbound)—has fundamentally altered the landscape of…
Human Sexuality Research & Journals Perceived weight stigma among adults diagnosed with schizophrenia in China: a cross-sectional study September 22, 2026 Lina Irawan A groundbreaking cross-sectional study published in Frontiers in Psychology has brought to light an overlooked crisis in psychiatric care: more than half of adults diagnosed with schizophrenia in China experience…
Psychology & Intimacy How Popular Weight-Loss Medications Are Rewriting Our Understanding of Addiction, Cravings, and the Brain September 15, 2026 Rebecca Shoemaker The mechanism by which the human brain translates a fleeting thought—such as the mental image of a savory meal or a cold beverage—into compulsive physical action has long been a…
Sexual Health & Medical Wellness Unintended Pregnancies Soar as Women on Popular Weight-Loss Medications Overlook Contraception, Raising Alarms Over Fetal Safety June 30, 2026 Susilo Ahmad Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers. This urgent call to action stems…
Global Lifestyle & Culture The Unexpected Weight of Another Year: Understanding the Global Phenomenon of Birthday Blues June 17, 2026 Gabriella Anastasia For many, the turn of a birthday signifies a time for celebration, reflection, and anticipation of the year ahead. Yet, for a significant portion of the global population, this annual…
Psychology & Intimacy Ozempic and Wegovy, Popular Diabetes and Weight-Loss Drugs, Show Surprising Mental Health Benefits in Landmark Study June 3, 2026 Rebecca Shoemaker A groundbreaking new study involving nearly 100,000 individuals has revealed that medications commonly prescribed for type 2 diabetes and obesity, including the widely recognized brands Ozempic and Wegovy, may offer…
